In response to the escalating challenges posed by the high drug resistance of rapidly growing mycobacteria (RGM), a collaborative team from the Qingdao Institute of Bioenergy and Bioprocess Technology ...

The laboratory diagnosis of Mycobacterium tuberculosis combines rapid molecular assays, microscopic examination and culture‐based methods to achieve both prompt detection and definitive confirmation.

October 23, 2006 (Las Vegas) — A test that permits the rapid sequencing and amplification of mycobacterial ribosomal RNA (rRNA) could be a good alternative to standard culturing methods when a fast ...

A new blood test to detect Mycobacteria in blood has been developed by a team at The University of Nottingham led by Dr Cath Rees, an expert in microbiology in the School of Biosciences and Dr Ben ...

Accurate detection is essential to prevent misdiagnosis and ensure the right treatment, particularly in cases involving drug-resistant TB or NTM infections. The Hi-PCR ® MTB/NTM Probe PCR Kit offers a ...

Inhaling nontuberculous mycobacteria is common for most people. The bacteria are found in water systems, soil and dust worldwide and, for many, cause no harm. For those with underlying conditions, ...

Fluoroquinolones and second-line injectable drugs are the backbone of treatment regimens for multidrug-resistant tuberculosis, and resistance to these drugs defines extensively drug-resistant ...

Researchers have developed a new highly sensitive blood test for tuberculosis (TB) that screens for DNA fragments of the Mycobacterium tuberculosis bacteria that causes the deadly disease. Researchers ...

A diagnostic tool has been developed to identify nontuberculous mycobacteria (NTM) infections, dramatically expediting the diagnostic process from 6 months to 2 hours. Regularly inhaling NTM may not ...

World-wide, Mycobacterium tuberculosis (Mtb) is responsible for the vast majority of tuberculosis (TB) cases. However, there are several other closely related mycobacterial species that cause TB, all ...

UK agri-tech start up PBD Biotech has developed what it claims is the “first rapid test for live mycobacteria”, closing a seed funding round that will accelerate its go-to-market strategy. Set up just ...